# A Clinical Study of YL205 in Patients With Advanced Solid Tumors

Source: https://onco.cc/trials/nct06459973/  
OnCo record `nct06459973` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 1/2 trial of intravenous (IV) infusion in advanced solid tumours, run by MediLink Therapeutics (Suzhou) Co., Ltd., now recruiting.

## Summary

A Clinical Study of YL205 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT06459973 by MediLink Therapeutics (Suzhou) Co., Ltd., with 252 participants planned, started 2024-06-04 and due to reach its primary completion in 2027-07-31. Interventions recorded: intravenous (IV) infusion.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT06459973
- Phase: 1/2
- Setting: A Multi-center, Open-label, Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of YL205 in Patients With Advanced Solid Tumors
- Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
- Enrolled: 252

## Sources

- ClinicalTrials.gov NCT06459973: https://clinicaltrials.gov/study/NCT06459973

## Connected records

- cancers: [Metastatic cancer (cancer that has spread)](https://onco.cc/cancers/metastatic-cancer/)

---
JSON: https://onco.cc/api/v1/entities/nct06459973.json